Biggest Hurdles to HealthTech Commercialisation Success
In the fast-paced and dynamic world of HealthTech, only one in five startups possesses the necessary commercial expertise within their team. Founders, often brilliant inventors, may lack the business acumen required for successful commercialisation. This underestimation of the commercialisation process, combined with an undue focus on product development, poses significant challenges. But why does this become a problem for so many HealthTech startups?
The Innovation Trap in HealthTech
Initially, it seems logical to focus on core innovations and assess the technological feasibility of your product. However, this is just one part of the equation for building a successful HealthTech company. Customers and investors won't automatically flock to your product or invest simply because you believe you've discovered the "holy grail" of solutions. Often, early-stage startups—particularly university spin-offs—find themselves with an impressive solution searching for a problem.
Beyond feasibility, the desirability of the product to customers and its financial viability are crucial components that are often overlooked. These elements form the backbone of successful commercialisation. When founders say that commercialisation isn't a priority for investors at their stage, or that their focus is solely on impact rather than B2B sales, it highlights a critical gap. So, why are these commercial aspects so frequently neglected?
The Importance of Early Commercialisation Strategy
One of the common pitfalls HealthTech startups fall into is delaying the development of a robust commercialisation strategy until late in the product development process. This often leads to rushed decisions, inefficient use of resources, and missed opportunities. A well-thought-out commercialisation strategy should be integrated from the start, running parallel with product development. This approach ensures that as the product evolves, so does its market fit, customer base, and revenue model
Market Research and Customer Validation
Market research is essential for any successful commercialisation effort, offering insights into customer needs, market size, and the competitive landscape. However, many HealthTech startups often underestimate its importance, relying on assumptions instead of data-driven decisions. Early customer validation, such as through interviews, surveys, and pilot programs, provides valuable feedback that refines the product and builds customer relationships, easing market entry.
According to Forbes, evaluating a HealthTech startup also involves understanding market demand, navigating regulatory challenges, and ensuring robust technology and scalability. Regular reassessment of the business model is crucial to stay competitive. For more detailed insights, you can read the full article here.
Top Challenges in HealthTech Commercialisation
1. Discomfort with the Unknown
Venturing beyond the R&D comfort zone is daunting, especially without immediate pressure to do so. Many HealthTech founders prefer to stay within their technical expertise, avoiding the commercial aspects that feel foreign and uncertain. However, embracing this discomfort is essential for long-term success. Founders must be willing to step out of their comfort zones and engage with the commercial side of the business, whether through education, mentorship, or bringing in external expertise.
2. Lack of Industry Experience
Without a clear understanding of the market, startups struggle to identify their true customers. The healthcare payment system is complex, with distinct roles for payers, users, decision-makers, and patients Navigating this landscape is not trivial and requires in-depth industry knowledge. Engaging with industry veterans, attending healthcare conferences, and participating in industry-specific training can help bridge this knowledge gap.
3. Absence of Connections
Science and engineering students often have limited interaction with business professionals. Even when they do, the healthcare market is so unique that traditional business experience may not suffice. This gap can leave startups without the necessary industry connections that are crucial for successful commercialisation. Building a strong network within the healthcare industry, including potential partners, investors, and advisors, is critical. Leveraging industry networks, attending specialised events, and actively seeking mentorship can help in building these essential connections.
4. Budget Constraints
Startups typically lack the funds to hire full-time commercial expertise. The multifaceted nature of commercialisation—spanning strategy, execution, and networking—requires a diverse skill set rarely found in a single individual willing to work for a modest salary. By the time such a person is found, the startup might have lost valuable time or even failed. However, there are alternatives to hiring full-time staff. Many startups are now turning to "CCO as a Service" models or interim commercial officers who can provide the necessary expertise at a fraction of the cost.
5. The Risk of Wrong Hires
Hiring missteps can be catastrophic for a HealthTech startup. As the saying goes, "Culture eats strategy for breakfast." Customer-facing roles are especially critical and often cannot be delegated by the founder CEO until processes are well-established. It’s important to take the time to find the right fit, even if it means delaying the hire. Consider using a rigorous hiring process that includes multiple interviews, cultural fit assessments, and trial periods to mitigate the risk of a bad hire.
Case Study on HealthTech Commercialisation Success
Biofourmis is a great example of a HealthTech startup that successfully navigated the challenges of commercialisation. Founded in 2015, Biofourmis focuses on digital therapeutics and personalized care, using wearable biosensors and artificial intelligence to improve patient outcomes.
Despite having innovative technology, Biofourmis initially struggled with market penetration due to the complex healthcare landscape and the need for regulatory approvals. To overcome these challenges, Biofourmis adopted a robust commercialisation strategy early in their development process. They conducted extensive market research, formed strategic partnerships with healthcare providers and pharmaceutical companies, and ensured compliance with regulatory standards across different regions.
This strategic approach paid off, leading to the successful launch of their flagship product, Biovitals®, and significant market traction globally. Biofourmis’s journey underscores the importance of integrating commercialisation efforts early in the development process to achieve success in the HealthTech industry
Are you a HealthTech startup founder looking to navigate the complexities of commercialisation? Don’t leave your groundbreaking innovation at the mercy of poor market fit or missed opportunities.
Got Questions: I’m here to help! Contact me here. I’d love to hear from you.
